StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSEAMERICAN:CANF – Get Rating) in a research note released on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $34.00 price objective on shares of Can-Fite BioPharma in a research report on Monday, March […]
Research analysts at StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Rating) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock. Can-Fite BioPharma Stock Performance Shares of Can-Fite BioPharma stock traded up $0.19 during trading on Wednesday, reaching $3.13. The company’s stock had a […]
Equities research analysts at StockNews.com started coverage on shares of Can-Fite BioPharma (NYSEAMERICAN:CANF – Get Rating) in a research note issued on Friday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $34.00 price objective on shares of Can-Fite BioPharma in a report […]
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSEAMERICAN:CANF – Get Rating) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $34.00 target price on shares of Can-Fite BioPharma in a report on Monday, […]